Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Winikoff

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
International Perspectives on Sexual and Reproductive Health|July 31, 2013
Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in BangladeshAnadil Alam, Hillary Bracken, Heidi Bart Johnston, et al.
The Lancet. Global Health|January 1, 2016
Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trialAyisha Diop, Bocar Daff, Maimouna Sow, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 4, 2003
Adaptation of kangaroo mother care for community-based applicationIftekhar Quasem, Nancy L Sloan, Anita Chowdhury, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 13, 2013
Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-upKelsey Lynd, Jennifer Blum, Nguyen Thi Nhu Ngoc, et al.
Contraception|November 27, 2012
Acceptability of home use of mifepristone for medical abortionYael Swica, Erica Chong, Tamer Middleton, et al.
Contraception|June 10, 2015
Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic reviewDaniel Grossman, Kari White, Lisa Harris, et al.
Journal of Health, Population, and Nutrition|August 25, 2005
Incidence of postpartum infection after vaginal delivery in Viet NamNguyen T N Ngoc, Nancy L Sloan, Tran S Thach, et al.
Contraception|January 15, 2019
Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studiesTara Shochet, Monica Dragoman, Jennifer Blum, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 8, 2013
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from UzbekistanSheila Raghavan, Tamar Tsereteli, Asamidin Kamilov, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 8, 2013
Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trialsSheila Raghavan, Galina Maistruk, Tara Shochet, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
International Perspectives on Sexual and Reproductive Health|July 31, 2013
Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in BangladeshAnadil Alam, Hillary Bracken, Heidi Bart Johnston, et al.
The Lancet. Global Health|January 1, 2016
Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trialAyisha Diop, Bocar Daff, Maimouna Sow, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 4, 2003
Adaptation of kangaroo mother care for community-based applicationIftekhar Quasem, Nancy L Sloan, Anita Chowdhury, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 13, 2013
Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-upKelsey Lynd, Jennifer Blum, Nguyen Thi Nhu Ngoc, et al.
Contraception|November 27, 2012
Acceptability of home use of mifepristone for medical abortionYael Swica, Erica Chong, Tamer Middleton, et al.
Contraception|June 10, 2015
Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic reviewDaniel Grossman, Kari White, Lisa Harris, et al.
Journal of Health, Population, and Nutrition|August 25, 2005
Incidence of postpartum infection after vaginal delivery in Viet NamNguyen T N Ngoc, Nancy L Sloan, Tran S Thach, et al.
Contraception|January 15, 2019
Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studiesTara Shochet, Monica Dragoman, Jennifer Blum, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 8, 2013
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from UzbekistanSheila Raghavan, Tamar Tsereteli, Asamidin Kamilov, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 8, 2013
Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: results of two clinical trialsSheila Raghavan, Galina Maistruk, Tara Shochet, et al.
Pageof 21